Lipase from Burkholderia cepacia (PSL-C) effectively catalyzed the kinetic resolution of both racemic trans-N,N-diallylcyclohex-4-ene-1,2-diamine (AE)-6 and its precursor trans-6-(diallylamino)cyclohex-3-enol (AE)-5. The resulting optically active vicinal diamine and b-amino alcohol were converted into a precursor of oseltamivir and a cis-cyclohex-4-ene-1,2-diamine derivative, respectively.
Introduction
Oseltamivir phosphate (1, Tamiflu), a carbocyclic analogue of sialic acid, is the most widely used antiviral drug for the treatment and prevention of influenzas. This compound acts by blocking the active site of neuraminidase, a glycoprotein expressed by both influenza A and B viruses. 1 Between the variety of synthetic approaches to oseltamivir, 2 those described by Shibasaki and Kanai et al. start from epoxide 4, which is converted into the optically active diamine derivative 2 3 or into another non-symmetrical diprotected trans-cyclohex-4-ene-1,2-diamine. 4 In both cases, eight steps were necessary to access to the corresponding (1S,2S)-diamine derivative, the key step being the catalytic asymmetric ring-opening of the meso-N-3,5-dinitrobenzoylaziridine 3 with TMSN 3 (Fig. 1 ).
On the other hand, we have developed in the last years an interesting chemoenzymatic method to obtain enantioenriched transcycloalkane-1,2-diamines starting from the corresponding epoxide. 5 The good results attained, in both optical and chemical yields, encouraged us to apply this methodology to the synthesis of optically active trans-cyclohex-4-ene-1,2-diamine derivatives. Thus, we report herein an alternative chemoenzymatic preparation of the diamine precursor of oseltamivir. Moreover, taking into account the wide interest of b-amino alcohols and vicinal diamines in different chemical areas (medicinal, synthetic or supramolecular), 6, 7 we also have carried out the enzymatic resolution of b-amino alcohol 5, as well as its subsequent conversion into an optically active cis-cyclohex-4-ene-1,2-diamine derivative.
Results and discussion
2.1. Chemoenzymatic preparation of optically active trans-cyclohex-4-ene-1,2-diamine derivatives Epoxide 4 was obtained from 1,4-cyclohexadiene as described by Albeck et al. 8 Ring-opening of 4 with diallylamine yielded racemic trans-6-(diallylamino)cyclohex-3-enol (AE)-5, which was one-pot converted into the trans-diamine (AE)-6 by the successive treatment with mesyl chloride and aqueous ammonia. In this process an aziridinium intermediate is formed as a consequence of the S N 2 intramolecular displacement of the mesylate group by the vicinal tertiary amine. The subsequent attack of ammonia to the meso-aziridinium cation ensures the trans configuration of the resulting diamine 6 (Scheme 1).
Resolution of (AE)-6 was accomplished by enzymatic aminolysis using ethyl acetate as the acyl donor and the solvent. At first, we tried the resolution of (AE)-6 using lipase B from Candida antarctica (CAL-B) as catalyst. This lipase had shown both great activity and high enantioselectivity in the resolution of racemic trans-N,N-diallylcyclohexane-1,2-diamine, a saturated analogue of (AE)-6. However, its reaction with (AE)-6 was very slow (Table 1 , entry 1), the acetylation of the diamine taking place with a very low enantioselectivity (E¼3). 9 Other combinations of acylating agent and solvent were assayed, but in no case was the reaction of practical utility (entries 2e4), the best result being obtained with (AE)-1-phenylethyl acetate and tert-butyl methyl ether (TBME). 10 Fortunately, a remarkable improvement was achieved when CAL-B was replaced by the lipase from Burkholderia cepacia (PSL-C). 11 This lipase transformed the substrate with total enantioselectivity, the remaining diamine (1S,2S)-6 and the produced acetamide (1R,2R)-7 being obtained in enantiopure form after 48 h of reaction (Table 1 , entry 5). In this process, both compounds were isolated in very high yields. The absolute configuration (1S,2S) of the remaining substrate 6 was established after its transformation into (1S,2S)-2 (see Scheme 2). This means that the enzyme shows preference for the enantiomer (1R,2R) of the amine, thus following the Kazlauskas' rule.
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Since the allyl groups on the tertiary nitrogen can be easily and selectively removed in the presence of other protecting groups, the method developed here could be applied to the synthesis of a variety of trans-cyclohex-4-ene-1,2-diamine derivatives in the two enantiomeric forms. As a proof, (1S,2S)-6 was converted into (1S,2S)-2, precursor of the oseltamivir (Scheme 2). Thus, treatment of (1S,2S)-6 with di-tert-butyl pyrocarbonate yielded carbamate (1S,2S)-8, which was submitted to reaction with N,N 0 -dimethylbarbituric acid (NDMBA) as the allyl group scavenger and Pd(0) as catalyst. 13 In these conditions, removal of both allyl groups took place. The resulting crude mono-Boc diamine derivative was next treated with di-tert-butyl pyrocarbonate to give (1S,2S)-2 in very high yield (92%, calculated from 6). The sign of the optical rotation of the thus obtained di-carbamate 2 matched the described value for (1S,2S)-2 (see Experimental section). configuration for the remaining substrate of the enzymatic transesterification.
Moreover, in order to show the synthetic utility of the enzymatically prepared compounds, the optically active cis-diamine derivative (1S,2R)-15 was prepared from the tert-butyl carbamate (1S,6S)-11. Thus, treatment of 11 with mesyl chloride gave the mesylate derivative, which was subsequently treated with sodium azide in DMF at 70 C. In this reaction, beside the cis-azido carbamate (1S,6R)-13, the oxazolidinone 14 was also isolated as a minor product (see experimental section). This bicyclic compound is the result of an intramolecular S N 2 displacement of the mesylate group by the carbonyl oxygen of the Boc group. 16 To minimize the formation of 14, the reaction with sodium azide was also tried at a lower temperature (50 C) but under these reaction conditions, compound 13 was not formed. Finally, the Staudinger reduction of the azide function of (1S,6R)-13 yielded the cis-amino carbamate (1S,2R)-15. In all the synthetic approaches no racemization took place as confirmed by chiral-HPLC analysis of 15.
Conclusions
Efficient chemoenzymatic approaches to optically active transcycohex-4-ene-1,2-diamine and trans-6-aminocyclohex-3-enol derivatives have been developed, in both cases the key step being the kinetic resolution of the corresponding racemic compound catalyzed by PSL-C. Moreover, the preparation of a precursor of oseltamivir as well as an optically active cis-cyclohex-4-ene-1,2-diamine derivative have also been carried out.
Experimental section

General
Lipase B from C. antarctica (Novozyme 435, available immobilized on polyacrylamide, 7300 PLU/g) was gifted by Novo Nordisk Co. Immobilized lipase from Burkholderia cepacia (PSL-C, 783 U/g) was purchased from Amano Pharmaceutical Co. For the enzymatic reactions, ethyl acetate of spectrophotometric grade (stored with 4 A molecular sieves), anhydrous TBME or THF and (AE)- To a cooled (0 C) solution of (AE)-5 (1.50 g, 7.70 mmol) in anhydrous diethyl ether (17 mL), triethylamine (1.7 mL, 12.4 mmol) and mesyl chloride (0.720 mL, 9.30 mmol) were added. The stirred mixture was allowed to warm to room temperature and, after 30 min, triethylamine (2.2 mL, 15.5 mmol) and concentrated aqueous NH 3 (20 mL) were added. The resulting two-phase reaction mixture was vigorously stirred for 12 h. The layers were separated, and the aqueous layer was extracted with diethyl ether (420 mL). All the organic layers were combined and successively washed with aqueous 3 M NaOH (20 mL) and brine (20 mL). After removal of the organic solvents under reduced pressure, the obtained crude product was purified by flash chromatography (a gradient of AcOEt to AcOEt/methanol 4:1 was used as eluent) to give the title compound (AE)-6 (78%) as a colourless oil; [found: C, 74. 
Enzymatic kinetic resolution of amino alcohol (AE)-5.
To a mixture of (AE)-5 (1.00 g, 5.10 mmol), PSL-C (520 mg) and 4 A from (1S,2S)-8 (0.58 mmol) . The allyl groups were removed following the method described by an analogous N,N-diallylcyclopentane-1,2-diamine. 17 The resulting crude mono-Boc diamine was subsequently dissolved in methanol (4 mL) and treated with di-tert-butyl pyrocarbonate (0.140 g, 0.64 mmol). After 5 h of reaction at room temperature, solvents were eliminated and the residue was subjected to flash chromatography (hexane/Et 2 O 7:3 as eluent) to yield the title compound (1S,2S)-2 (94%). Spectroscopic data are in good agreement with those previously reported. It was obtained by previous mesylation of (1S,6S)-11 (0.115 g, 0.54 mmol) with mesyl chloride following the procedure described. 18 Then, the crude mesyl derivative was dissolved in anhydrous N,N-dimethylformamide (1.0 mL) and sodium azide (0.105 g, 1.62 mmol) was added. After heating the mixture at 70 C during 24 h, ethyl acetate (5 mL) was added and the organic solution was repeatedly washed with water. The organic phase was dried with Na 2 SO 4 , and evaporated to reduce pressure to give a residue, which was subjected to flash chromatography (hexane/ 
HPLC determination of the enantiomeric excesses
The ee for each compound obtained in the enzymatic resolutions as well as for the cis-diamine derivative 15 was determined by chiral HPLC using Chiralpack-IA column. Compounds 5 and 7 were analyzed directly. Amino ester 9 was previously converted into the amino alcohol 5 by hydrolysis with a 0.50 M methanolic solution of NaOH. trans-Diamine 6 was transformed into its tert-butyl carbamate derivative 8. The chemoenzymatically prepared cis-amino carbamate 15 was treated with acetic anhydride and the resulting amido carbamate analysed. Results obtained in the analysis of racemic samples are as follows:
Amino alcohol (AE)-5: hexane/ethanol 98:2, 0.8 mL/min, 30 C; t R ¼8.9 (1R,6R) and 11.6 (1S,6S) min; R S ¼4.3.
Amino amide (AE)-7: hexane/ethanol 95:5, 0.8 mL/min, 30 C; t R ¼10.4 (1R,2R) and 14.4 (1S,2S) min; R S ¼6.0.
Amino carbamate (AE)-8: hexane/ethanol 98:2, 0.8 mL/min, 30 C; t R ¼5.6 (1R,2R) and 6.8 (1S,2S) min; R S ¼3.3.
Amido carbamate derived from (AE)-15: hexane/propan-2-ol 90:10, 0.8 mL/min, 30 C; t R ¼17.3 (1S,2R) and 20.4 (1R,2S) min; R S ¼2.6.
